Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | casein kinase I delta | 0.0384 | 1 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0384 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-D protein kinase | 0.0384 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0384 | 1 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0376 | 0.9567 | 0.9567 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0384 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0306 | 0.5801 | 0.5801 |
Entamoeba histolytica | casein kinase, putative | 0.0384 | 1 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0384 | 1 | 1 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.0306 | 0.5801 | 0.5801 |
Echinococcus multilocularis | casein kinase I alpha | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0384 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0384 | 1 | 1 |
Brugia malayi | casein kinase I | 0.0384 | 1 | 1 |
Echinococcus granulosus | casein kinase I delta | 0.0384 | 1 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0384 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0384 | 1 | 1 |
Onchocerca volvulus | 0.0376 | 0.9567 | 0.9567 | |
Toxoplasma gondii | casein kinase I | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0384 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0384 | 1 | 1 |
Onchocerca volvulus | 0.0384 | 1 | 1 | |
Brugia malayi | Protein kinase domain containing protein | 0.0306 | 0.5801 | 0.5801 |
Schistosoma mansoni | protein kinase | 0.0384 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0384 | 1 | 1 |
Echinococcus multilocularis | casein kinase I gamma | 0.0306 | 0.5801 | 0.5801 |
Echinococcus granulosus | casein kinase I alpha | 0.0384 | 1 | 1 |
Loa Loa (eye worm) | casein kinase | 0.0298 | 0.5368 | 0.5368 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0384 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0384 | 1 | 1 |
Echinococcus multilocularis | casein kinase i | 0.0384 | 1 | 1 |
Trypanosoma brucei | casein kinase I, isoform 2 | 0.0384 | 1 | 1 |
Echinococcus granulosus | casein kinase i | 0.0384 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0384 | 1 | 1 |
Echinococcus granulosus | casein kinase I gamma | 0.0306 | 0.5801 | 0.5801 |
Entamoeba histolytica | casein kinase 1, putative | 0.0384 | 1 | 1 |
Leishmania major | casein kinase, putative | 0.0384 | 1 | 1 |
Plasmodium vivax | casein kinase 1, putative | 0.0384 | 1 | 1 |
Plasmodium falciparum | casein kinase 1 | 0.0384 | 1 | 1 |
Giardia lamblia | Kinase, CK1 Casein kinase | 0.0384 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.